259 related articles for article (PubMed ID: 26211927)
1. Primary Cytomegalovirus Infection Significantly Impacts Circulating T Cells in Kidney Transplant Recipients.
Meijers RW; Litjens NH; Hesselink DA; Langerak AW; Baan CC; Betjes MG
Am J Transplant; 2015 Dec; 15(12):3143-56. PubMed ID: 26211927
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus mismatch still negatively affects patient and graft survival in the era of routine prophylactic and preemptive therapy: A paired kidney analysis.
Leeaphorn N; Garg N; Thamcharoen N; Khankin EV; Cardarelli F; Pavlakis M
Am J Transplant; 2019 Feb; 19(2):573-584. PubMed ID: 30431703
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients.
Egli A; Binet I; Binggeli S; Jäger C; Dumoulin A; Schaub S; Steiger J; Sester U; Sester M; Hirsch HH
J Transl Med; 2008 Jun; 6():29. PubMed ID: 18541023
[TBL] [Abstract][Full Text] [Related]
4. Easier Control of Late-Onset Cytomegalovirus Disease Following Universal Prophylaxis Through an Early Antiviral Immune Response in Donor-Positive, Recipient-Negative Kidney Transplants.
Kaminski H; Couzi L; Garrigue I; Moreau JF; Déchanet-Merville J; Merville P
Am J Transplant; 2016 Aug; 16(8):2384-94. PubMed ID: 26953216
[TBL] [Abstract][Full Text] [Related]
5. CMV-infected kidney grafts drive the expansion of blood-borne CMV-specific T cells restricted by shared class I HLA molecules via presentation on donor cells.
Gatault P; Al-Hajj S; Noble J; Chevallier E; Piollet M; Forconi C; Gaudy-Graffin C; Thibault G; Miquelestorena-Standley E; Halimi JM; Büchler M; Lemoine R; Baron C
Am J Transplant; 2018 Aug; 18(8):1904-1913. PubMed ID: 29377506
[TBL] [Abstract][Full Text] [Related]
6. Impaired direct priming of CD8 T cells by donor-derived cytomegalovirus following kidney transplantation.
Shabir S; Kaul B; Pachnio A; Banham GD; Smith H; Chand S; Jham S; Harper L; Ball S; Rahbar A; Söderberg-Nauclér C; Moss P; Borrows R
J Am Soc Nephrol; 2013 Oct; 24(10):1698-708. PubMed ID: 23847277
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus-Associated CD4(+) CD28(null) Cells in NKG2D-Dependent Glomerular Endothelial Injury and Kidney Allograft Dysfunction.
Shabir S; Smith H; Kaul B; Pachnio A; Jham S; Kuravi S; Ball S; Chand S; Moss P; Harper L; Borrows R
Am J Transplant; 2016 Apr; 16(4):1113-28. PubMed ID: 26603521
[TBL] [Abstract][Full Text] [Related]
8. Sepsis after renal transplantation: Clinical, immunological, and microbiological risk factors.
Schachtner T; Stein M; Reinke P
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28296035
[TBL] [Abstract][Full Text] [Related]
9. A randomized, phase 2 study of ASP0113, a DNA-based vaccine, for the prevention of CMV in CMV-seronegative kidney transplant recipients receiving a kidney from a CMV-seropositive donor.
Vincenti F; Budde K; Merville P; Shihab F; Ram Peddi V; Shah M; Wyburn K; Cassuto-Viguier E; Weidemann A; Lee M; Flegel T; Erdman J; Wang X; Lademacher C
Am J Transplant; 2018 Dec; 18(12):2945-2954. PubMed ID: 29745007
[TBL] [Abstract][Full Text] [Related]
10. CMV Primary Infection Is Associated With Donor-Specific T Cell Hyporesponsiveness and Fewer Late Acute Rejections After Liver Transplantation.
Shi XL; de Mare-Bredemeijer EL; Tapirdamaz Ö; Hansen BE; van Gent R; van Campenhout MJ; Mancham S; Litjens NH; Betjes MG; van der Eijk AA; Xia Q; van der Laan LJ; de Jonge J; Metselaar HJ; Kwekkeboom J
Am J Transplant; 2015 Sep; 15(9):2431-42. PubMed ID: 25943855
[TBL] [Abstract][Full Text] [Related]
11. Virus-Specific CD8(+) T Cells Cross-Reactive to Donor-Alloantigen Are Transiently Present in the Circulation of Kidney Transplant Recipients Infected With CMV and/or EBV.
Heutinck KM; Yong SL; Tonneijck L; van den Heuvel H; van der Weerd NC; van der Pant KA; Bemelman FJ; Claas FH; Ten Berge IJ
Am J Transplant; 2016 May; 16(5):1480-91. PubMed ID: 26603974
[TBL] [Abstract][Full Text] [Related]
12. Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment.
Fernández-Ruiz M; Giménez E; Vinuesa V; Ruiz-Merlo T; Parra P; Amat P; Montejo M; Paez-Vega A; Cantisán S; Torre-Cisneros J; Fortún J; Andrés A; San Juan R; López-Medrano F; Navarro D; Aguado JM;
Clin Microbiol Infect; 2019 Mar; 25(3):381.e1-381.e10. PubMed ID: 29803844
[TBL] [Abstract][Full Text] [Related]
13. High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function.
Nickel P; Bold G; Presber F; Biti D; Babel N; Kreutzer S; Pratschke J; Schönemann C; Kern F; Volk HD; Reinke P
Transpl Immunol; 2009 Mar; 20(4):238-42. PubMed ID: 19032982
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus contributes partly to uraemia-associated premature immunological ageing of the T cell compartment.
Meijers RW; Litjens NH; de Wit EA; Langerak AW; van der Spek A; Baan CC; Weimar W; Betjes MG
Clin Exp Immunol; 2013 Dec; 174(3):424-32. PubMed ID: 23962178
[TBL] [Abstract][Full Text] [Related]
15. Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation.
Ettenger R; Chin H; Kesler K; Bridges N; Grimm P; Reed EF; Sarwal M; Sibley R; Tsai E; Warshaw B; Kirk AD
Am J Transplant; 2017 Jun; 17(6):1549-1562. PubMed ID: 27989013
[TBL] [Abstract][Full Text] [Related]
16. Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients.
Ishiyama K; Arakawa-Hoyt J; Aguilar OA; Damm I; Towfighi P; Sigdel T; Tamaki S; Babdor J; Spitzer MH; Reed EF; Sarwal MM; Lanier LL;
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35181606
[TBL] [Abstract][Full Text] [Related]
17. Pharmacoepidemiology of cytomegalovirus prophylaxis in a large retrospective cohort of kidney transplant recipients with Medicare Part D coverage.
Santos CA; Brennan DC; Saeed MJ; Fraser VJ; Olsen MA
Clin Transplant; 2016 Apr; 30(4):435-44. PubMed ID: 26841129
[TBL] [Abstract][Full Text] [Related]
18. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
[TBL] [Abstract][Full Text] [Related]
19. Impact of donor and recipient human cytomegalovirus status on kidney transplantation.
Zielinski M; Tarasewicz A; Zielinska H; Jankowska M; Moszkowska G; Debska-Slizien A; Rutkowski B; Trzonkowski P
Int Immunol; 2017 Dec; 29(12):541-549. PubMed ID: 29121254
[TBL] [Abstract][Full Text] [Related]
20. Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs.
Schlott F; Steubl D; Hoffmann D; Matevossian E; Lutz J; Heemann U; Hösel V; Busch DH; Renders L; Neuenhahn M
PLoS One; 2017; 12(1):e0171035. PubMed ID: 28129395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
